HOME >> BIOLOGY >> NEWS
Growth factor receptor signaling critical to intestinal tumor development, studies show

CHAPEL HILL Scientists at the University of North Carolina at Chapel Hill and Vanderbilt University say they have uncovered a major clue to what causes and promotes development of intestinal tumors.

Working with laboratory mice, the researchers found that a molecule called epidermal growth factor receptor (Egfr) is necessary for most intestinal tumors to form. Their work also suggests that a drug or genetic manipulation that inhibits the receptors chemical signaling machinery should help treat advanced colorectal cancers in humans one day.

A report on the findings appears online today (Jan. 29) in the latest edition of the Proceedings of the National Academy of Sciences. Authors include doctoral student Reade B. Roberts and Dr. David W. Threadgill, assistant professor of genetics, both at the UNC School of Medicines Lineberger Comprehensive Cancer Center, and Dr. Robert J. Coffey, a cell biologist at Vanderbilt.

This Egfr receptor is very important to all kinds of tissues and organs, but there hasnt been any genetic proof in whole animals that it could affect a major cancer like colon cancer, Reade said. We think this work represents proof because it relied on genetic experiments that were highly controlled compared with just injecting mice with drugs and hoping that they would affect the receptor.

At UNC, the researchers studied two kinds of mice. They engineered one set to include a mutation called Apc-Min, which produces both human and mouse intestinal cancers, and another mutation known as waved 2, in which the Egfr was partially impaired. The other mice, litter mates of the first group, bore the same Apc-Min mutation, but also had normal Egfr genes.

Within three months, the first group developed 90 percent fewer intestinal polyps than the second, which showed that Egfr signaling was critical to intestinal tumor formation, scientists found. Some of the first group developed no tumors at all.

Surprisingly the size
'"/>

Contact: David Williamson
david_williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
29-Jan-2002


Page: 1 2

Related biology news :

1. Growth hormone and IBD: Reduction of intestinal inflammation, promotion of growth
2. Growth study of wild chimpanzees challenges assumptions about early humans
3. Growth hormone activates gene involved in healing damaged tissue
4. Growth factor shows promise in Parkinsons patients
5. Growth hormone could make farm fish bigger, faster to market
6. Growth hormone may stimulate production of T cells to boost bodys ability to fight HIV
7. Growth hormone may boost production of disease-fighting cells in elderly
8. Growth factor may determine who grows new blood vessels that protect against heart attacks
9. Growth hormone involved in diabetic kidney disease, study finds
10. Report: High Carbon Dioxide Boosts Duke Forest Growth By 25 Percent
11. UC Berkeley Conference On Population Growth And The Environment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/3/2019)... ... October 01, 2019 , ... ... dispensing of chemicals, reagents, and medias and to be a more environmentally sustainable ... the culmination of years of experience and feedback from the original version we ...
(Date:9/30/2019)... ... September 30, 2019 , ... As human induced pluripotent stem cells (hiPSCs) ... the development and diseases of the human heart, there is an increasing need for ... muscle cells to be clearly and easily recorded. A study released today in STEM ...
(Date:9/25/2019)... (PRWEB) , ... September 25, 2019 , ... ... biopharma leaders through off-the-record collaboration and dialogue, today announces its inaugural South ... Orleans BioInnovation Center in Louisiana. , Co-produced by Tulane University, this invitation-only ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... Fla. (PRWEB) , ... September 16, 2019 , ... ... broadcast Nationwide via CNBC on Saturday, September 21st @11:00am ET. Check local listings ... Biomedical Pte. Ltd. (Credo Biomedical), a molecular diagnostic company from Singapore dedicated ...
(Date:9/11/2019)... CONSHOHOCKEN, Pa. (PRWEB) , ... September 09, 2019 ... ... Interactive Response Technology (IRT) for clinical trial randomization and drug supply chain management, ... software provider for the global life sciences industry. , “The integration between Veeva ...
(Date:9/9/2019)... , ... September 09, 2019 , ... Visikol CEO Dr. ... that was focused on how best to characterize 3D cell culture models. The inherent ... they are too thick and opaque to image through and therefore traditional wide-field or ...
(Date:9/4/2019)... ... September 03, 2019 , ... ... solutions for drugs, biologics, gene therapies, and consumer health products, today announced ... upcoming Nordic Life Science Days (NLS Days) conference, being held at the ...
Breaking Biology Technology:
Cached News: